Editorial: The MARS trial: Resolution of the surgical controversies in mesothelioma?

Journal of Thoracic Oncology

Volumn 4, Issue 10, 2009, Pages 1189-1191

  Rusch, Valerie W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; HEALTH CARE SYSTEM; HEALTH INSURANCE; LUNG RESECTION; MORBIDITY; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME; UNITED STATES; HUMAN; MESOTHELIOMA; NOTE; PATHOLOGY; PLEURA; PLEURA TUMOR; RANDOMIZED CONTROLLED TRIAL;

HUMANS; MESOTHELIOMA; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 70349680524     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181b7d470     Document Type: Editorial

References (14)

1. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65.
2. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1996;111:815-826.
3. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) in the surgical management of malignant pleural mesothelioma (MPM): results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-626.
4. Rusch VW, Rosenzweig K, Venkatraman E, et al. A Phase II trial of surgical resection and adjuvant high dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122: 788-795.
5. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1684-1693.
6. Treasure T, Utley M. Ten traps for the unwary in surgical series: A case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133: 1414-1418.
7. Treasure T, Utley M. Mesothelioma: benefit from surgical resection is questionable. J Thorac Oncol 2007;2:885-886.
8. Treasure T, Waller D, Tan C, et al. The mesothelioma and radical surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009;4:1254-1258.
9. Flores RM, Routledge T, Seshan VE, et al. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2008; 136:605-610.
10. Weder W, Stahel RA, Bernhard J, et al; Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-1202.
11. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase 2 trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneu-monectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007-3013.
12. Schipper PH, Nichols FC, Thomse KM, et al. Malignant pleural me-sothelioma: surgical management in 285 patients. Ann Thorac Surg 2008;85:257-264.
13. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 2008; 34:886-891.
14. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decorti-cation for pathological N2 malignant pleural mesothelioma. Eur J Car-diothorac Surg 2007;31:765-771.